Hopkins, A. L. & Groom, C. R. The druggable genome. Nat. Rev. Drug Discov. 1, 727–730 (2002).

Article  CAS  PubMed  Google Scholar 

Pan, Q., Shai, O., Lee, L. J., Frey, B. J. & Blencowe, B. J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413–1415 (2008). This article, together with Wang et al., 2008 (ref. 4), demonstrates that most genes undergo alternative splicing.

Article  CAS  PubMed  Google Scholar 

Sinitcyn, P. et al. Global detection of human variants and isoforms by deep proteome sequencing. Nat. Biotechnol. 41, 1776–1786 (2023). Provides evidence that most frame-preserving alternative splicing events give rise to detectable protein isoforms.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008). This article, together with Pan et al., 2008 (ref. 2), demonstrates that most genes undergo alternative splicing and that alternative transcripts contribute substantially to total transcripts.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weatheritt, R. J., Sterne-Weiler, T. & Blencowe, B. J. The ribosome-engaged landscape of alternative splicing. Nat. Struct. Mol. Biol. 23, 1117–1123 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kjer-Hansen, P. & Weatheritt, R. J. The function of alternative splicing in the proteome: rewiring protein interactomes to put old functions into new contexts. Nat. Struct. Mol. Biol. 30, 1844–1856 (2023). Summarizes the way in which alternative splicing alters the interaction of proteins with all the major classes of biological macromolecule with impacts on almost every cellular processes.

Article  CAS  PubMed  Google Scholar 

Onkal, R. et al. Alternative splicing of Nav1.5: an electrophysiological comparison of ‘neonatal’ and ‘adult’ isoforms and critical involvement of a lysine residue. J. Cell Physiol. 216, 716–726 (2008).

Article  CAS  PubMed  Google Scholar 

Pang, P. D. et al. CRISPR-mediated expression of the fetal Scn5a isoform in adult mice causes conduction defects and arrhythmias. J. Am. Heart Assoc. 7, e010393 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Veerman, C. C. et al. Switch from fetal to adult SCN5A isoform in human induced pluripotent stem cell-derived cardiomyocytes unmasks the cellular phenotype of a conduction disease-causing mutation. J. Am. Heart Assoc. 6, e005135 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Freyermuth, F. et al. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat. Commun. 7, 11067 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, R., Helbig, I., Edmondson, A. C., Lin, L. & Xing, Y. Splicing defects in rare diseases: transcriptomics and machine learning strategies towards genetic diagnosis. Brief. Bioinform. 24, bbad284 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Li, Y. I. et al. RNA splicing is a primary link between genetic variation and disease. Science 352, 600–604 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim, W. F. & Rinaldi, C. RNA transcript diversity in neuromuscular research. J. Neuromuscul. Dis. 10, 473–482 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Quesnel-Vallieres, M., Weatheritt, R. J., Cordes, S. P. & Blencowe, B. J. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat. Rev. Genet. 20, 51–63 (2019).

Article  CAS  PubMed  Google Scholar 

Bradley, R. K. & Anczukow, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23, 135–155 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krawczak, M. et al. Single base-pair substitutions in exon–intron junctions of human genes: nature, distribution, and consequences for mRNA splicing. Hum. Mutat. 28, 150–158 (2007).

Article  CAS  PubMed  Google Scholar 

Vanoye, C. G. et al. Molecular and cellular context influences SCN8A variant function. JCI Insight 9, e177530 (2024).

Article  PubMed  Google Scholar 

Abayev-Avraham, M., Salzberg, Y., Gliksberg, D., Oren-Suissa, M. & Rosenzweig, R. DNAJB6 mutants display toxic gain of function through unregulated interaction with Hsp70 chaperones. Nat. Commun. 14, 7066 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Splawski, I. et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004).

Article  CAS  PubMed  Google Scholar 

Graham, W. V. et al. Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis. Nat. Med. 25, 690–700 (2019). Demonstrates that an isoform-specific IgCAM domain in MLCK1 can be targeted through rational drug design so MLCK1 is a possible target in treatment of gastrointestinal disease.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horowitz, A., Chanez-Paredes, S. D., Haest, X. & Turner, J. R. Paracellular permeability and tight junction regulation in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 20, 417–432 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Batista, N. J. et al. The molecular and cellular basis of Hutchinson–Gilford progeria syndrome and potential treatments. Genes 14, 602 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nikom, D. & Zheng, S. Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat. Rev. Neurosci. 24, 457–473 (2023).

Article  CAS  PubMed  Google Scholar 

Baralle, M. & Baralle, F. E. Alternative splicing and liver disease. Ann. Hepatol. 26, 100534 (2021).

Article  CAS  PubMed  Google Scholar 

Ren, P. et al. Alternative splicing: a new cause and potential therapeutic target in autoimmune disease. Front. Immunol. 12, 713540 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoy, S. M. Nusinersen: first global approval. Drugs 77, 473–479 (2017).

Article  CAS  PubMed  Google Scholar 

Kim, J. et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N. Engl. J. Med. 381, 1644–1652 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scaglioni, D. et al. The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy. Acta Neuropathol. Commun. 9, 7 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh, R. N., Ottesen, E. W. & Singh, N. N. The first orally deliverable small molecule for the treatment of spinal muscular atrophy. Neurosci. Insights 15, 2633105520973985 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome. Nature 423, 293–298 (2003).

Article